Tower Research Capital LLC (Trc) Context Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 934 shares of CNTX stock, worth $625. This represents 0.0% of its overall portfolio holdings.
Number of Shares
934
Previous 7,155
86.95%
Holding current value
$625
Previous $14,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CNTX
# of Institutions
55Shares Held
72.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$9.85 Million2.18% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$5.01 Million0.84% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$4.97 Million0.32% of portfolio
-
Nextech Invest Ag7.42MShares$4.97 Million1.37% of portfolio
-
Blue Owl Capital Holdings LP New York, NY6.36MShares$4.26 Million2.69% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $10.7M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...